Paper33430278
The Next Generation of Influenza Vaccines: Towards a Universal Solution.
McMillan CLD and 3 others. Vaccines (Basel), 2021. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. The Next Generation of Influenza Vaccines: Towards a Universal Solution. Papers, record 33430278. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33430278
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References129
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26641724 | Strategies towards universal pandemic influenza vaccines. | Expert Rev Vaccines | 2016 | https://conductscience.org/library/papers/26641724 | PubMed |
| 2 | 19840661 | M2e-based universal influenza A vaccine. | Vaccine | 2009 | https://conductscience.org/library/papers/19840661 | PubMed |
| 3 | 26167164 | Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype. | Front Immunol | 2015 | https://conductscience.org/library/papers/26167164 | PubMed |
| 4 | 30764577 | Emerging Influenza D Virus Threat: What We Know so Far! | J Clin Med | 2019 | https://conductscience.org/library/papers/30764577 | PubMed |
| 5 | 20870054 | Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant. | Vaccine | 2010 | https://conductscience.org/library/papers/20870054 | PubMed |
| 6 | 19135117 | A multi-valent vaccine approach that elicits broad immunity within an influenza subtype. | Vaccine | 2009 | https://conductscience.org/library/papers/19135117 | PubMed |
| 7 | 24595369 | Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family. | mBio | 2014 | https://conductscience.org/library/papers/24595369 | PubMed |
| 8 | 29992986 | The influenza virus hemagglutinin head evolves faster than the stalk domain. | Sci Rep | 2018 | https://conductscience.org/library/papers/29992986 | PubMed |
| 9 | 11294672 | Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus. | J Infect Dis | 2001 | https://conductscience.org/library/papers/11294672 | PubMed |
| 10 | 19729082 | Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses. | Vaccine | 2009 | https://conductscience.org/library/papers/19729082 | PubMed |
| 11 | 29100705 | Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine. | Vaccine | 2018 | https://conductscience.org/library/papers/29100705 | PubMed |
| 12 | 23029232 | Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge. | PLoS One | 2012 | https://conductscience.org/library/papers/23029232 | PubMed |
| 13 | 23991187 | Low seroprevalent species D adenovirus vectors as influenza vaccines. | PLoS One | 2013 | https://conductscience.org/library/papers/23991187 | PubMed |
| 14 | 9682352 | Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. | Vaccine | 1998 | https://conductscience.org/library/papers/9682352 | PubMed |
| 15 | 26549362 | Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine. | Vaccine | 2015 | https://conductscience.org/library/papers/26549362 | PubMed |
| 16 | 24279313 | Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. | Curr Gene Ther | 2013 | https://conductscience.org/library/papers/24279313 | PubMed |
| 17 | 26026378 | Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses. | Vaccine | 2015 | https://conductscience.org/library/papers/26026378 | PubMed |
| 18 | 25695754 | Reassortant highly pathogenic influenza A(H5N6) virus in Laos. | Emerg Infect Dis | 2015 | https://conductscience.org/library/papers/25695754 | PubMed |
| 19 | 7464906 | Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. | Nature | 1981 | https://conductscience.org/library/papers/7464906 | PubMed |
| 20 | 33288923 | A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial. | Nat Med | 2021 | https://conductscience.org/library/papers/33288923 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42722670 | Single-component self-assembling protein nanoparticles displaying stabilized prefusion-closed hemagglutinin trimers for influenza vaccine development. | Nat Commun | 2026 | https://conductscience.org/library/papers/42722670 | PubMed |
| 42645432 | Advances in the Development of a Universal Influenza Vaccine. | Antibodies (Basel) | 2026 | https://conductscience.org/library/papers/42645432 | PubMed |
| 41279549 | Mucosal delivery of influenza antigens using a replication deficient adenovirus supports broadly reactive antibody responses and heterologous viral immunity in the respiratory tract of animals. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279549 | PubMed |
| 41012618 | Use of the Slow-Delivery Platform, VacSIM, Shapes the Host Immune Response to Increase Protection Against Influenza Infection. | Viruses | 2025 | https://conductscience.org/library/papers/41012618 | PubMed |
| 39360831 | Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials. | Clin Microbiol Rev | 2024 | https://conductscience.org/library/papers/39360831 | PubMed |
| 39111250 | A broad-spectrum multiepitope vaccine against seasonal influenza A and B viruses in mice. | EBioMedicine | 2024 | https://conductscience.org/library/papers/39111250 | PubMed |
| 38793789 | DNA Vaccine Encoding a Modified Hemagglutinin Trimer of Avian Influenza A Virus H5N8 Protects Mice from Viral Challenge. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38793789 | PubMed |
| 38793788 | Very Broadly Effective Hemagglutinin-Directed Influenza Vaccines with Anti-Herpetic Activity. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38793788 | PubMed |
| 38430907 | Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase. | Immunity | 2024 | https://conductscience.org/library/papers/38430907 | PubMed |
| 37988765 | Single-Component Multilayered Self-Assembling Protein Nanoparticles Displaying Extracellular Domains of Matrix Protein 2 as a Pan-influenza A Vaccine. | ACS Nano | 2023 | https://conductscience.org/library/papers/37988765 | PubMed |
| 37338377 | A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection. | J Virol | 2023 | https://conductscience.org/library/papers/37338377 | PubMed |
| 37293549 | Temperature impacts Atlantic salmon's (Salmo salar) immunological response to infectious salmon anemia virus (ISAv). | Fish Shellfish Immunol Rep | 2023 | https://conductscience.org/library/papers/37293549 | PubMed |
| 36721506 | Assessment of influenza A (H1N1, H3N2) oseltamivir resistance during 2017-2019 in Iran. | Iran J Microbiol | 2022 | https://conductscience.org/library/papers/36721506 | PubMed |
| 36258770 | Identification of antigens recognized by salivary IgA using microbial protein microarrays. | Biosci Microbiota Food Health | 2022 | https://conductscience.org/library/papers/36258770 | PubMed |
| 35089583 | Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2. | J Microbiol | 2022 | https://conductscience.org/library/papers/35089583 | PubMed |
| 34696304 | Fear of Influenza Resurgence amid COVID-19 Pandemic: Need for Effective Flu Vaccine Still Exists. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34696304 | PubMed |
| 34576851 | A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies. | Microorganisms | 2021 | https://conductscience.org/library/papers/34576851 | PubMed |
| 34372526 | Targeting Viral Surface Proteins through Structure-Based Design. | Viruses | 2021 | https://conductscience.org/library/papers/34372526 | PubMed |
| 34202178 | Conserved Influenza Hemagglutinin, Neuraminidase and Matrix Peptides Adjuvanted with ALFQ Induce Broadly Neutralizing Antibodies. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34202178 | PubMed |
| 33916924 | Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/33916924 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ARHGAP45 | 23526 | PubTator's text mining | https://conductscience.org/library/genes/23526 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD6 | 923 | PubTator's text mining | https://conductscience.org/library/genes/923 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| HAS1 | 3036 | PubTator's text mining | https://conductscience.org/library/genes/3036 | NCBI Gene |
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 | NCBI Gene |
| MYO1G | 64005 | PubTator's text mining | https://conductscience.org/library/genes/64005 | NCBI Gene |
| NEU1 | 4758 | PubTator's text mining | https://conductscience.org/library/genes/4758 | NCBI Gene |
| PBRM1 | 55193 | PubTator's text mining | https://conductscience.org/library/genes/55193 | NCBI Gene |
| SNORA73A | 6080 | PubTator's text mining | https://conductscience.org/library/genes/6080 | NCBI Gene |
| USB1 | 79650 | PubTator's text mining | https://conductscience.org/library/genes/79650 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33430278
GET https://conductscience.org/api/papers/v1/33430278/references?page=2